YOR214C Antibody

What is YOR214C and what cellular functions does it perform?

YOR214C is an Open Reading Frame in Saccharomyces cerevisiae that encodes a GPI-anchored protein located in the cell wall. This protein contains potential N-glycosylation sites and has been studied for its role in cell wall integrity and biogenesis. The amino acid sequence of YOR214C includes a characteristic ω-minus region: "PTITPGNITT IGG YE N SSSSLMPSMGILSFLFGLYLLLHP *" with demonstrated cell wall incorporation values of 0.338 ± 0.065 in quantitative assays .

YOR214C functions as a membrane protein that likely participates in cell-surface activities, similar to other GPI-anchored proteins that contribute to cell wall structure and function. Its specific biological role relates to maintaining proper cell wall architecture, which is essential for yeast cell survival, growth, and response to environmental stresses.

What methodologies are recommended for validating YOR214C antibodies?

When validating antibodies against YOR214C, researchers should implement genetic approach strategies rather than relying solely on orthogonal approaches, as genetic techniques have demonstrated superior reliability in antibody validation. Studies have shown that antibodies validated using knockout (KO) or knockdown (KD) cell lines as controls yield significantly more reliable results than those validated through orthogonal methods alone .

For proper validation, researchers should:

• Test the antibody against wild-type yeast expressing YOR214C

• Compare signal against a YOR214C knockout strain (negative control)

• Perform Western blotting to confirm antibody specificity and the presence of a single band at the expected molecular weight

• Conduct immunofluorescence studies in both wild-type and knockout strains

• Verify results using immunoprecipitation followed by mass spectrometry identification

Research indicates that approximately 89% of antibodies recommended based on genetic validation strategies successfully detect their intended target proteins, compared to only 80% of those validated using orthogonal approaches .

How should researchers troubleshoot non-specific binding with YOR214C antibodies?

Non-specific binding is a common challenge when working with yeast antibodies, particularly for membrane proteins like YOR214C. To address this issue, researchers should implement the following methodological approaches:

• Optimize blocking conditions: Test different blocking agents (BSA, milk, commercial blockers) at various concentrations to reduce background signal.

• Adjust antibody concentration: Titrate primary antibody concentrations to find the optimal signal-to-noise ratio. For Western blotting, start with 1:1000 dilution and adjust based on results.

• Include genetic controls: Always run samples from YOR214C knockout strains alongside experimental samples to identify non-specific bands or signals.

• Pre-adsorb antibodies: Incubate antibodies with lysate from knockout cells to remove antibodies that bind to non-specific targets before using in experiments.

• Validate across multiple techniques: Cross-validate antibody specificity using multiple techniques (Western blot, immunofluorescence, immunoprecipitation), as some antibodies may perform better in certain applications than others .

Data indicates that for 55 out of 65 target proteins in validation studies, researchers successfully identified at least one antibody that specifically detected the target protein. For the remaining targets, researchers found antibodies that could detect the protein but also recognized unrelated proteins (non-specific bands not eliminated in knockout controls) .

What are the most effective approaches for detecting post-translational modifications of YOR214C?

YOR214C contains potential N-glycosylation sites that are critical for its function . To effectively study these modifications, researchers should employ a multi-technique approach:

• Enzymatic deglycosylation assays: Treat protein samples with endoglycosidases (PNGase F, Endo H) and compare mobility shifts on Western blots to identify N-linked glycosylation.

• Lectin affinity approaches: Use lectin blotting or lectin affinity chromatography with different lectins (ConA, WGA) to detect specific glycan structures on YOR214C.

• Mass spectrometry analysis: Perform glycopeptide enrichment followed by LC-MS/MS to identify specific glycosylation sites and glycan compositions. This is particularly important for identifying heterogeneous glycan populations.

• Site-directed mutagenesis: Create mutants of predicted N-glycosylation sites (N-X-S/T motifs) and assess functional consequences through phenotypic assays.

• Specialized antibodies: Develop or use antibodies that specifically recognize glycosylated forms of YOR214C.

For comprehensive glycoproteomic analysis of yeast proteins like YOR214C, researchers should integrate their antibody-based studies with global glycoproteomic approaches as described in comprehensive studies of the yeast glycoproteome .

How can YOR214C antibodies be used to study protein-protein interactions in the yeast cell wall?

To effectively study YOR214C interactions with other cell wall proteins, researchers can employ the following methodological approaches:

• Co-immunoprecipitation with targeted controls:

  • Perform IP with YOR214C antibodies from non-denaturing cell lysates

  • Validate interactions using reciprocal IPs with antibodies against suspected interaction partners

  • Include appropriate controls (knockout strains, IgG controls)

  • Confirm interactions by Western blotting with validated antibodies

• Proximity labeling approaches:

  • Fuse YOR214C to enzymes like BioID or APEX2

  • Identify proximal proteins through biotin labeling and streptavidin pulldown

  • Confirm interactions using YOR214C antibodies

• Cross-linking mass spectrometry:

  • Use chemical cross-linkers to stabilize transient interactions

  • Immunoprecipitate YOR214C using validated antibodies

  • Identify cross-linked peptides by mass spectrometry

• Fluorescence microscopy co-localization:

  • Combine YOR214C antibody staining with markers for other cell wall components

  • Use super-resolution microscopy for detailed spatial analysis

  • Quantify co-localization using appropriate statistical methods

All 614 antibodies in comprehensive validation studies were tested by immunoprecipitation on non-denaturing cell lysates for intracellular proteins or cell media for secreted proteins, with Western blotting used to evaluate the immunocapture efficacy .

What are effective strategies for using YOR214C antibodies in flow cytometry applications?

Flow cytometry has become increasingly important for antibody screening and cell sorting in yeast studies. For effective use of YOR214C antibodies in flow cytometry applications, researchers should:

• Optimize cell preparation:

  • Use enzymatic treatment (zymolyase or lyticase) to partially digest the cell wall

  • Fix cells with paraformaldehyde (2-4%) to maintain antibody epitopes

  • Permeabilize cell membrane with mild detergents if YOR214C epitopes are intracellular

• Antibody labeling optimization:

  • Titrate antibody concentrations to determine optimal signal-to-noise ratio

  • Use directly conjugated antibodies when possible to reduce background

  • Include appropriate isotype controls and knockout cell controls

• Multicolor panel design:

  • Carefully select fluorophore combinations to minimize spectral overlap

  • Include viability dyes to exclude dead cells from analysis

  • Use compensation controls when multiple fluorophores are employed

• Fluorescence-activated cell sorting (FACS):

  • For hybridoma screening, label target antigens with fluorescent tags

  • Analyze fluorescent signals as cells pass through laser beams

  • Cells expressing antibodies that bind the fluorescent antigen will fluoresce with greater intensity than cells with weak or no antigen binding

FACS technology has proven invaluable for therapeutic antibody development, contributing to over 100 approved monoclonal antibodies for human therapies and at least 140 more in late-stage development .

How can researchers apply yeast display technology to develop improved YOR214C antibodies?

Yeast display technology offers powerful approaches for antibody discovery and engineering that can be applied to develop improved YOR214C antibodies:

• Library construction and screening:

  • Develop a billion-member antibody library displayed on yeast surface

  • Screen against purified YOR214C protein to identify high-affinity binders

  • Use multiple rounds of selection with decreasing antigen concentration to isolate the highest affinity clones

• Incorporation of noncanonical amino acids:

  • Utilize polyspecific orthogonal translation systems to introduce chemical groups with various properties

  • Incorporate photo-reactive, proximity-reactive, or click chemistry-enabled functional groups

  • Create "protein-small molecule hybrid" antibodies with enhanced binding properties

• Affinity maturation:

  • Apply error-prone PCR to create libraries of antibody variants

  • Use FACS to select variants with improved binding characteristics

  • Combine beneficial mutations to develop antibodies with superior specificity and affinity

• Confirmation and validation:

  • Perform flow cytometry analysis to confirm binding properties

  • Test antibodies against YOR214C knockout controls

  • Validate in multiple application formats (Western blot, IP, IF)

This approach has successfully produced antibodies against challenging targets, with yeast display technology enabling the identification of several clones that bind strongly to target proteins of interest .

What are the optimal conditions for using YOR214C antibodies in Western blotting?

For optimal Western blot results with YOR214C antibodies, researchers should follow these methodological guidelines based on validation studies of hundreds of antibodies:

• Sample preparation:

  • For intracellular proteins like YOR214C, prepare cell lysates under non-denaturing conditions

  • For secreted proteins, collect and concentrate cell media

  • Include protease inhibitors to prevent degradation

  • Consider the use of phosphatase inhibitors if phosphorylation is of interest

• Electrophoresis conditions:

  • Use gradient gels (4-20%) to optimize separation

  • Carefully control loading to avoid overloading, which can lead to non-specific bands

  • Include molecular weight markers appropriate for the expected size of YOR214C

• Transfer and blocking:

  • Optimize transfer conditions based on protein molecular weight

  • Test different blocking solutions (milk, BSA, commercial blockers) to reduce background

  • Use validated blocking conditions that don't interfere with antibody recognition

• Antibody incubation:

  • Start with manufacturer's recommended dilution and optimize as needed

  • Incubate at 4°C overnight for primary antibody to maximize specific binding

  • Use appropriate HRP-conjugated secondary antibodies

• Controls:

  • Always include knockout cell lysates as negative controls

  • Consider using recombinant YOR214C as a positive control where available

Studies have shown that for Western blotting, about 80% of antibodies recommended based on orthogonal strategies and 89% of antibodies recommended based on genetic strategies could detect their intended target proteins .

What experimental strategies help distinguish true YOR214C signals from artifacts?

To ensure that observed signals truly represent YOR214C and not experimental artifacts, researchers should implement the following methodological approaches:

• Genetic validation:

  • Always include samples from YOR214C knockout strains as negative controls

  • Use strains with tagged versions of YOR214C (e.g., HA, FLAG) to confirm antibody specificity

  • Consider knockdown approaches (RNAi, CRISPR interference) when knockouts are not viable

• Multiple antibody validation:

  • Use multiple antibodies targeting different epitopes of YOR214C

  • Compare results across antibodies to identify consistent patterns

  • Be aware that different antibodies may recognize different post-translational modifications

• Signal verification techniques:

  • Perform peptide competition assays to confirm specificity

  • Use recombinant expression of YOR214C or fragments as positive controls

  • Implement mass spectrometry confirmation of immunoprecipitated proteins

• Cross-technique validation:

  • Verify results using multiple techniques (WB, IF, IP)

  • Be aware that some antibodies may perform better in certain applications

  • Document all validation results systematically

Comprehensive studies have found that while 61% of antibodies for Western blotting were recommended based on orthogonal approaches, the most reliable validations came from the 30% that were validated using genetic approaches .

How can researchers optimize immunofluorescence protocols for YOR214C localization studies?

For precise localization of YOR214C using immunofluorescence, researchers should implement these methodological refinements:

• Cell preparation:

  • Optimize fixation methods (formaldehyde, methanol) for YOR214C epitope preservation

  • Test different cell wall digestion protocols to improve antibody accessibility

  • Consider spheroplasting to remove the cell wall completely for challenging epitopes

• Permeabilization optimization:

  • Test different detergents (Triton X-100, saponin) at various concentrations

  • Optimize permeabilization time to balance antibody access with morphology preservation

  • Consider mild permeabilization for membrane proteins to prevent epitope destruction

• Antibody incubation conditions:

  • Perform antibody titration to determine optimal concentration

  • Test different incubation temperatures and times

  • Use validated blocking reagents to minimize background fluorescence

• Co-localization studies:

  • Include markers for cellular compartments (ER, Golgi, plasma membrane)

  • Use spectral unmixing for multicolor imaging

  • Employ appropriate co-localization statistics and controls

• Advanced imaging techniques:

  • Consider super-resolution microscopy for detailed localization studies

  • Use deconvolution to improve image quality

  • Implement quantitative image analysis for objective assessment

Validation studies have shown that only 38% of antibodies recommended for immunofluorescence based on orthogonal strategies were confirmed using knockout cells as controls, highlighting the importance of proper validation for this application .

How do cell wall modifications affect YOR214C antibody accessibility?

The yeast cell wall presents unique challenges for antibody accessibility to membrane proteins like YOR214C. Researchers should consider the following methodological approaches:

• Cell wall digestion optimization:

  • Test different enzymatic treatments (zymolyase, lyticase, glusulase)

  • Optimize enzyme concentration and digestion time

  • Monitor cell integrity during digestion using microscopy

• Cell wall mutant strains:

  • Use strains with altered cell wall composition (e.g., gas1Δ, kre6Δ)

  • Consider temperature-sensitive cell wall mutants

  • Be aware that cell wall mutations may affect YOR214C localization or expression

• Fixation considerations:

  • Test crosslinking fixatives (formaldehyde) versus precipitating fixatives (methanol)

  • Optimize fixation time to balance epitope preservation with antibody accessibility

  • Consider post-fixation treatments to improve epitope exposure

• Antigen retrieval techniques:

  • Adapt heat-mediated or enzymatic antigen retrieval methods for yeast cells

  • Test different pH conditions for optimal epitope exposure

  • Validate that retrieval methods don't alter protein localization

YOR214C contains a characteristic GPI-attachment sequence and has a cell wall incorporation value of 0.338 ± 0.065, indicating its integration into the cell wall structure . This incorporation may affect antibody accessibility and should be considered when designing experiments.

What approaches help overcome limitations in YOR214C antibody specificity?

To address specificity limitations that may occur with YOR214C antibodies, researchers should implement these methodological strategies:

• Epitope mapping and antibody selection:

  • Identify unique epitopes in YOR214C that differ from related proteins

  • Select antibodies targeting these unique regions

  • Consider developing custom antibodies against specific YOR214C domains

• Pre-absorption techniques:

  • Incubate antibodies with lysates from YOR214C knockout cells

  • Remove antibodies binding to non-specific targets

  • Validate pre-absorbed antibodies in multiple applications

• Signal validation approaches:

  • Use peptide competition assays with specific and non-specific peptides

  • Implement immunodepletion studies to confirm specificity

  • Compare signals across multiple antibodies targeting different YOR214C epitopes

• Advanced purification techniques:

  • Consider affinity purification of antibodies using recombinant YOR214C

  • Test both polyclonal and monoclonal antibodies for your application

  • Evaluate domain-specific antibodies when studying specific regions of YOR214C

For 9 out of 65 target proteins in validation studies, researchers identified at least one specific, non-selective antibody that detects the cognate protein but also recognizes unrelated proteins (non-specific bands not lost in knockout controls) . This highlights the importance of rigorous validation, particularly for yeast membrane proteins.

How can researchers integrate YOR214C antibody data with other -omics approaches?

For comprehensive understanding of YOR214C function, researchers should integrate antibody-based studies with other -omics approaches using these methodological strategies:

• Integrating with transcriptomics:

  • Correlate YOR214C protein levels (via antibodies) with mRNA expression data

  • Study protein-mRNA relationships under different conditions

  • Identify potential post-transcriptional regulation mechanisms

• Combining with proteomics:

  • Use antibodies for targeted validation of mass spectrometry findings

  • Implement immunoprecipitation followed by mass spectrometry (IP-MS)

  • Compare relative quantification by antibody-based methods versus MS-based methods

• Integration with glycoproteomics:

  • Use YOR214C antibodies to validate glycoproteomic findings

  • Study site-specific glycosylation at potential N-glycosylation sites

  • Correlate glycoproteomic data with YOR214C function and localization

• Computational integration strategies:

  • Develop data integration pipelines combining antibody-derived data with -omics datasets

  • Use statistical approaches to identify correlations across datasets

  • Implement network analysis to identify functional relationships

Studies examining the yeast glycoproteome have established methods for global analysis of protein glycosylation , which can be complemented with YOR214C-specific antibody studies to provide detailed insights into this protein's modifications and functions.

How might emerging antibody engineering technologies improve YOR214C research?

Recent advances in antibody engineering offer promising approaches to enhance YOR214C research:

• Chemically diversified antibody libraries:

  • Billion-member antibody libraries incorporating noncanonical amino acids

  • Introduction of chemical groups with photo-reactive, proximity-reactive properties

  • Bioorthogonal click chemistry conjugations to expand antibody functionality

• Yeast display technologies:

  • Selection of high-affinity YOR214C binders from vast antibody libraries

  • Identification of antibodies with improved specificity and sensitivity

  • Development of antibodies that recognize specific post-translational modifications

• Site-specific modification approaches:

  • Incorporation of O-(2-bromoethyl)tyrosine (OBeY) for proximity-induced crosslinking

  • Development of antibodies capable of forming covalent bonds with YOR214C

  • Enhanced stability of antibody-antigen complexes under stringent conditions

• Advanced screening methodologies:

  • Flow cytometry-based screening for antibodies with superior binding characteristics

  • Retention of binding after denaturation as a measure of robust interaction

  • Selection for antibodies that recognize native conformations of YOR214C

These technologies offer new opportunities for identifying and characterizing antibodies with properties beyond what is accessible with conventional approaches, potentially enabling discovery of new classes of research reagents and diagnostic tools for YOR214C studies .

What role could YOR214C antibodies play in understanding yeast cell wall biogenesis?

YOR214C antibodies can provide valuable insights into yeast cell wall biogenesis through these methodological approaches:

• Temporal and spatial localization studies:

  • Track YOR214C localization during different growth phases

  • Monitor changes in distribution during cell wall stress

  • Study co-localization with other cell wall synthesis machinery

• Functional interaction mapping:

  • Use YOR214C antibodies for co-immunoprecipitation studies

  • Identify protein complexes involved in GPI-anchor processing

  • Map interactions with cell wall synthesis enzymes

• Quantitative analysis of incorporation:

  • Measure YOR214C levels in cell wall fractions under different conditions

  • Correlate with quantitative values of cell wall incorporation (0.338 ± 0.065)

  • Study the relationship between glycosylation state and cell wall incorporation

• Genetic interaction studies:

  • Combine YOR214C antibody studies with analyses of deletion strains

  • Investigate proteins like Sur4, Csg2, Erv14, and Emp24 that affect cell surface function

  • Determine how disruption of these genes affects YOR214C localization and function

Studies have shown that YOR214C has potential N-glycosylation sites within sequences used for fusion protein construction , which may play critical roles in its cell wall functions and interactions with other components of the cell wall biogenesis machinery.